The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expanding criteria for prognostic stage IA disease in HR+ breast cancer.
 
Olga Kantor
No Relationships to Disclose
 
Tari A. King
Honoraria - Genomic Health
Consulting or Advisory Role - Genomic Health
Travel, Accommodations, Expenses - Grupo Oncoclinicas
 
Steven Shak
Employment - Exact Sciences; Genomic Health
Leadership - Genomic Health
Stock and Other Ownership Interests - Exact Sciences; Genomic Health
Patents, Royalties, Other Intellectual Property - Genomic Health
 
Christy Ann Russell
Employment - Exact Sciences; Genomic Health International
Stock and Other Ownership Interests - Genomic Health International
Honoraria - Genentech/Roche; Genomic Health; Novartis; Pfizer
Speakers' Bureau - Genentech/Roche; Genomic Health; Novartis; Pfizer
Travel, Accommodations, Expenses - Genentech/Roche; Genomic Health; Novartis; Pfizer
 
Armando E. Giuliano
No Relationships to Disclose
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Agendia; Novartis; Peregrine Pharmaceuticals
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Harold J. Burstein
No Relationships to Disclose
 
Eric P. Winer
Stock and Other Ownership Interests - Verastem
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - Carrick Therapeutics; G1 Therapeutics; Genomic Health; GlaxoSmithKline; Jounce Therapeutics; Leap Therapeutics; Lilly; Seagen
Research Funding - Genentech (Inst); Novartis (Inst)
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Cardinal Health; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Roche/Genentech
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Genomic Health; Merck; Merck; Peregrine Pharmaceuticals; Sellas Life Sciences; TapImmune Inc.
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline